1. Home
  2. ODC vs ENGN Comparison

ODC vs ENGN Comparison

Compare ODC & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$57.88

Market Cap

706.2M

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$11.12

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODC
ENGN
Founded
1941
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
706.2M
605.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ODC
ENGN
Price
$57.88
$11.12
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$22.71
AVG Volume (30 Days)
68.0K
399.3K
Earning Date
03-10-2026
03-09-2026
Dividend Yield
1.42%
N/A
EPS Growth
17.33
N/A
EPS
3.63
N/A
Revenue
$478,113,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.95
N/A
Revenue Growth
5.29
N/A
52 Week Low
$41.37
$2.65
52 Week High
$69.76
$12.25

Technical Indicators

Market Signals
Indicator
ODC
ENGN
Relative Strength Index (RSI) 69.59 64.90
Support Level $47.51 $8.68
Resistance Level $60.00 $12.25
Average True Range (ATR) 1.57 0.83
MACD 0.80 0.27
Stochastic Oscillator 82.70 72.42

Price Performance

Historical Comparison
ODC
ENGN

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: